Pages that link to "Q45744790"
Jump to navigation
Jump to search
The following pages link to Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection (Q45744790):
Displaying 50 items.
- The causes and consequences of HIV evolution (Q22251040) (← links)
- Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies (Q24561905) (← links)
- Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? (Q26765043) (← links)
- Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination (Q26776518) (← links)
- Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 (Q26782237) (← links)
- HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies (Q26799624) (← links)
- Designing synthetic vaccines for HIV (Q26862617) (← links)
- HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
- The Antibody Response against HIV-1 (Q27000889) (← links)
- Antibodies in HIV-1 vaccine development and therapy (Q27011574) (← links)
- Challenges in mucosal HIV vaccine development: lessons from non-human primate models (Q27022152) (← links)
- A global approach to HIV-1 vaccine development (Q27024614) (← links)
- Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy (Q27313556) (← links)
- Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site (Q27316899) (← links)
- HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization (Q27324184) (← links)
- An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV (Q27349203) (← links)
- Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 (Q27469855) (← links)
- Wanted, dead or alive: New viral vaccines (Q27489979) (← links)
- Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion (Q27641682) (← links)
- A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies (Q27655865) (← links)
- Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies (Q27674878) (← links)
- Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding (Q27675486) (← links)
- A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition (Q27676864) (← links)
- Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody (Q27677011) (← links)
- Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies (Q27678352) (← links)
- Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor (Q27684529) (← links)
- Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization (Q28068018) (← links)
- Immunopathogenesis and immunotherapy in AIDS virus infections (Q28183667) (← links)
- Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. (Q28217208) (← links)
- Antisperm Contraceptive Vaccines: Where We Are and Where We Are Going? (Q28235213) (← links)
- The good and evil of complement activation in HIV-1 infection (Q28275986) (← links)
- Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B (Q28469023) (← links)
- Retracted: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector (Q28533970) (← links)
- Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy (Q28654490) (← links)
- Measurements of immune responses for establishing correlates of vaccine protection against HIV (Q28728189) (← links)
- Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells (Q28732043) (← links)
- A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein (Q28743092) (← links)
- A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines (Q30234577) (← links)
- Survivors Remorse: antibody-mediated protection against HIV-1. (Q30238730) (← links)
- Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials. (Q30328005) (← links)
- Progress in HIV vaccine research. (Q30331429) (← links)
- Innate and adaptive mucosal immunity in protection against HIV infection. (Q30332881) (← links)
- Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. (Q30369026) (← links)
- The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies (Q30374404) (← links)
- 25 years of HIV research! ... and what about a vaccine? (Q30379637) (← links)
- Current views on the potential for development of a HIV vaccine (Q30397595) (← links)
- Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F (Q30398490) (← links)
- Association of interleukin 4 VNTR polymorphism and HIV/AIDS in a north Indian seropositive patients (Q30404329) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies (Q30408097) (← links)